abstract |
The present invention provides a humanized monoclonal antibody having an immunostimulatory effect. The antibody specifically binds to B lymphocytes, induces proliferation and activity of peripheral blood lymphocytes, and can elicit anticancer effects when administered to patients suffering from cancer. |